Literature DB >> 20858325

[Laboratory diagnosis of acute Q fever].

Marjolijn C A Wegdam-Blans1, Marrigje N Nabuurs-Franssen, Alphons M Horrevorts, Marcel F Peeters, Peter M Schneeberger, Henk A Bijlmer.   

Abstract

In the Netherlands an increasing number of laboratories are involved in diagnosing acute Q-fever. More uniformity in diagnostics and interpretation is desirable. To enable this, a working group on diagnostics of acute Q-fever was created on the initiative of the National Institute for Public Health and the Environment (RIVM) and the Dutch Association for Medical Microbiology (NVMM). The diagnostics of acute Q-fever includes a diagnostic flow chart (algorithm) consisting of tests for DNA and for antibodies against the antigens that appear in the successive stages of the disease. Reporting of both confirmed and suspected cases of acute Q-fever is obligatory.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20858325

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN： 0028-2162


  9 in total

1.  A Q Fever Outbreak in the Netherlands: Consequences for Tissue Banking.

Authors:  Marja J van Wijk; Boris M Hogema; D Willemijn Maas; Arlinke G Bokhorst
Journal:  Transfus Med Hemother       Date:  2011-11-14       Impact factor: 3.747

2.  Evaluation of commonly used serological tests for detection of Coxiella burnetii antibodies in well-defined acute and follow-up sera.

Authors:  M C A Wegdam-Blans; C C H Wielders; J Meekelenkamp; J M Korbeeck; T Herremans; H T Tjhie; H A Bijlmer; M P G Koopmans; P M Schneeberger
Journal:  Clin Vaccine Immunol       Date:  2012-05-23

3.  Correlations between peripheral blood Coxiella burnetii DNA load, interleukin-6 levels, and C-reactive protein levels in patients with acute Q fever.

Authors:  M N T Kremers; R Janssen; C C H Wielders; L M Kampschreur; P M Schneeberger; P M Netten; A de Klerk; H M Hodemaekers; M H A Hermans; D W Notermans; P C Wever
Journal:  Clin Vaccine Immunol       Date:  2014-01-29

4.  Identification of risk factors for chronic Q fever, the Netherlands.

Authors:  Linda M Kampschreur; Sandra Dekker; Julia C J P Hagenaars; Peter J Lestrade; Nicole H M Renders; Monique G L de Jager-Leclercq; Mirjam H A Hermans; Cornelis A R Groot; Rolf H H Groenwold; Andy I M Hoepelman; Peter C Wever; Jan Jelrik Oosterheert
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

5.  The health status of Q-fever patients after long-term follow-up.

Authors:  Gabriëlla Morroy; Jeannette B Peters; Malou van Nieuwenhof; Hans H J Bor; Jeannine L A Hautvast; Wim van der Hoek; Clementine J Wijkmans; Jan H Vercoulen
Journal:  BMC Infect Dis       Date:  2011-04-18       Impact factor: 3.090

6.  Differentiation of Acute Q Fever from Other Infections in Patients Presenting to Hospitals, the Netherlands

Authors:  Stephan P Keijmel; Elmer Krijger; Corine E Delsing; Tom Sprong; Marrigje H Nabuurs-Franssen; Chantal P Bleeker-Rovers
Journal:  Emerg Infect Dis       Date:  2015-08       Impact factor: 6.883

7.  Screening of post-mortem tissue donors for Coxiella burnetii infection after large outbreaks of Q fever in The Netherlands.

Authors:  Marja J van Wijk; D Willemijn Maas; Nicole Hm Renders; Mirjam H A Hermans; Hans L Zaaijer; Boris M Hogema
Journal:  BMC Infect Dis       Date:  2014-01-06       Impact factor: 3.090

8.  Large regional differences in serological follow-up of Q fever patients in the Netherlands.

Authors:  Gabriëlla Morroy; Cornelia C H Wielders; Mandy J B Kruisbergen; Wim van der Hoek; Jan H Marcelis; Marjolijn C A Wegdam-Blans; Clementine J Wijkmans; Peter M Schneeberger
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

9.  Pediatric acute Q fever mimics other common childhood illnesses.

Authors:  Ingeborg Y Bart; Yvonne Schabos; Roeland W N M van Hout; Alexander C A P Leenders; Esther de Vries
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.